240 related articles for article (PubMed ID: 17264762)
1. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
Ogura T; Tajika M; Niwa Y; Kawai H; Kondo S; Sawaki A; Mizuno N; Hara K; Hijioka S; Nakamura M; Higuchi K; Goto H; Yamao K
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1712-9. PubMed ID: 21971145
[TBL] [Abstract][Full Text] [Related]
5. Immunohemolytic anemia following oxaliplatin administration.
Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
[No Abstract] [Full Text] [Related]
6. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
Ito I; Ito Y; Mizuno M; Suzuki Y; Yasuda K; Ozaki T; Kosugi T; Yasuda Y; Sato W; Tsuboi N; Maruyama S; Imai E; Matsuo S
Clin Exp Nephrol; 2012 Jun; 16(3):490-4. PubMed ID: 22450906
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin-induced Evan's syndrome.
Earle CC; Chen WY; Ryan DP; Mayer RJ
Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
[No Abstract] [Full Text] [Related]
8. Oxaliplatin-induced immune pancytopenia.
Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
[TBL] [Abstract][Full Text] [Related]
9. A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use.
Wolf B; Conradty M; Grohmann R; Rüther E; Witzgall H; Londong V
J Clin Psychiatry; 1989 Mar; 50(3):99-100. PubMed ID: 2925599
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
11. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
Nozawa H; Muto Y; Yamada Y
Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
[TBL] [Abstract][Full Text] [Related]
12. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
Shao YY; Hong RL
Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
[TBL] [Abstract][Full Text] [Related]
14. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.
Santodirocco M; Lombardi V; Fesce C; Palumbo G; Capalbo S; Landriscina M
Acta Oncol; 2008; 47(8):1602-4. PubMed ID: 18607839
[No Abstract] [Full Text] [Related]
15. Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer.
Mundt P; Mochmann HC; Ebhardt H; Zeitz M; Duchmann R; Pauschinger M
Oncology; 2007; 73(3-4):270-2. PubMed ID: 18424892
[TBL] [Abstract][Full Text] [Related]
16. Acute ototoxicity from a single infusion of oxaliplatin.
Malhotra NK; Aslam R; Lipman SP; Bilski VJ
Ear Nose Throat J; 2010 Jun; 89(6):258-61. PubMed ID: 20556736
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Land SR; Kopec JA; Cecchini RS; Ganz PA; Wieand HS; Colangelo LH; Murphy K; Kuebler JP; Seay TE; Needles BM; Bearden JD; Colman LK; Lanier KS; Pajon ER; Cella D; Smith RE; O'Connell MJ; Costantino JP; Wolmark N
J Clin Oncol; 2007 Jun; 25(16):2205-11. PubMed ID: 17470850
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
Petrioli R; Pascucci A; Francini E; Marsili S; Sciandivasci A; Tassi R; Civitelli S; Tanzini G; Lorenzi M; Francini G
Cancer Chemother Pharmacol; 2008 Jan; 61(1):105-11. PubMed ID: 17429632
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion of oxaliplatin for a patient with hepatic metastases from colon cancer undergoing hemodialysis.
Shitara K; Munakata M; Muto O; Okada R; Mitobe S; Mino M; Ikami I; Sakata Y
Jpn J Clin Oncol; 2007 Jul; 37(7):540-3. PubMed ID: 17675650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
